MedPath

Association study between single nucleotide polymorphisms of glycogen synthase kinase -3 (GSK-3) and a specific group of patients with diagnostic conversion from depression to bipolar disorder and finally to dementia.

Not Applicable
Recruiting
Conditions
Depression, bipolar disorder, dementia
Registration Number
JPRN-UMIN000041145
Lead Sponsor
Oita University Faculty of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
600
Inclusion Criteria

Not provided

Exclusion Criteria

Subjects who are judged as inappropriate one at the discretion of the doctors.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Genotypic and allelic distributions of GSK-3 single nucleotide polymorphism. To compare the group of dementia with the past history of mood disorder (depression or bipolar disorder) and the group of dementia without.
Secondary Outcome Measures
NameTimeMethod
Genotypic and allelic distributions of GSK-3 single nucleotide polymorphism. To investigate genetic association of the group of patients whose diagnosis is not changed from depression to bipolar disorder.
© Copyright 2025. All Rights Reserved by MedPath